[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hypermarcas SA - Strategy, SWOT and Corporate Finance Report

January 2017 | 22 pages | ID: HD8BB64B2B8EN
MarketLine

US$ 175.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Hypermarcas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

KEY FINDINGS
  • Detailed information on Hypermarcas SA required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Hypermarcas SA in the form of a SWOT analysis
  • An in-depth view of the business model of Hypermarcas SA including a breakdown and examination of key business segments
  • Intelligence on Hypermarcas SA's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Hypermarcas SA, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
REASONS TO BUY
  • Gain understanding of Hypermarcas SA and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Hypermarcas SA as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Hypermarcas SA's business structure, strategy and prospects.
KEY HIGHLIGHTS

Hypermarcas SA (Hypermarcas) is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax, Neo Química Zero-Cal, Finn and Adocyl. Its products are distributed directly to retailers through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers located in Anapolis and Goiania, Brazil. Hypermarcas is headquartered in Sao Paulo, Brazil.
Company Snapshot
  Hypermarcas SA: Company Overview
  Hypermarcas SA: Overview and Key Facts
    Hypermarcas SA: Overview
    Hypermarcas SA: Key Facts
  Hypermarcas SA: Key Employees
  Hypermarcas SA: Major Products and Services
  Hypermarcas SA: Company History
  Hypermarcas SA: Management Statement
  Hypermarcas SA: Locations and Subsidiaries
  Hypermarcas SA: Key Competitors
Hypermarcas SA: Company Analysis
  Hypermarcas SA: Business Description
  Hypermarcas SA: SWOT Analysis
    Hypermarcas SA: SWOT Overview
    Hypermarcas SA: Strengths
    Hypermarcas SA: Weaknesses
    Hypermarcas SA: Opportunities
    Hypermarcas SA: Threats
Appendix
  Contact Us
  Methodology
  Definitions
  About Datamonitor

LIST OF TABLES

Table 1: Hypermarcas SA: Key Facts
Table 2: Hypermarcas SA: Key Employees
Table 4: Hypermarcas SA: Key Competitors

COMPANIES MENTIONED

Hypermarcas SA


More Publications